Clinical trial NCT03068117 - References

Mesothelioma, Malignant — Malignant Mesothelioma - Can we Improve Quality of Life

Citation(s)

•   Hollen PJ, Gralla RJ, Liepa AM, Symanowski JT, Rusthoven JJ
  Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: using the LCSS-Meso conceptual model for validation. Cancer. 2004 Aug 1;101(3):587-95.
•   Hollen PJ, Gralla RJ, Liepa AM, Symanowski JT, Rusthoven JJ
  Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso. Support Care Cancer. 2006 Jan;14(1):11-21. Epub 2005 Jul 6.
•   Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M
  The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol. 2000 Apr;55(1):19-25.
•   Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR
  Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer. 2001 Feb-Mar;31(2-3):233-40.
•   Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ
  Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678.

A Multicentre, Non-blinded, Randomised Controlled Trial to Assess the Impact of Regular Early SPEcialist Symptom Control Treatment on Quality of Life in Malignant Mesothelioma - "RESPECT-Meso"

Details for clinical trial NCT03068117